The Clinical Times
The Front Page of Medicine

Drugs & FDA

Drug approvals, label changes, and FDA drug news.

FDA Drugs · Jun 9, 2026

Consumer and Health Care Professional Information

Compounded drugs can serve an important medical need for patients who cannot be treated with an FDA-approved drug, such as a patient who has an allergy and needs a drug to be made without a certain dye, or a child who cannot swallow a tablet or capsule and needs a medicine in a liquid dosage form.

FDA Drugs · Jun 9, 2026

Accelerating Product Development for Pediatric Systemic Lupus Erythematosus (SLE) - 07/30/2026

The U.S. Food and Drug Administration (FDA), with the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI), will host a workshop, “Accelerating Product Development for Pediatric Systemic Lupus Erythematosus” on July 30-31, 2026. This workshop will examine key similarities and differences between adult and pedia

FDA Drugs · Jun 9, 2026

Understanding the Risks of Compounded Drugs

Compounded drugs are not FDA-approved. This means the agency does not verify their safety, effectiveness or quality before they are marketed. Learn more.

FDA Drugs · Jun 9, 2026

Compounding Safety Information: Quinacrine Hydrochloride

Quinacrine appears on the FDA 503B list of bulk drug substances that may be used in ccompounded drugs. FDA’s review for the 503B Bulks List determined that there is a clinical need for drug products compounded from quinacrine in the treatment of some patients with cutaneous lupus erythematosus.

FDA Drugs · Jun 9, 2026

Sunscreen: How to Help Protect Your Skin from the Sun

How you use sunscreens, and what other protective measures you take, make a difference in how well you are able to protect yourself and your family from sunburn, skin cancer, early skin aging and other risks of overexposure to the sun.

Older →

Back to the live front page